Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion type Assertion NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_head.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion wasGeneratedBy ECO_0000203 NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_provenance.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion wasDerivedFrom befree-2016 NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_provenance.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion SIO_000772 11714450 NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_provenance.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion evidence source_evidence_literature NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_provenance.
- NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_assertion description "[Paclitaxel and SN-38 (an active metabolite of irinotecan (CPT-11)) are two drugs that are effective in patients with DDP-resistant ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336875.RAXx6sHHM38sawnoocOGfdZ_iE-1lfeUAjT0kA_e67c-I130_provenance.